We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Is Baxter International (BAX) Stock Outpacing Its Medical Peers This Year?
Read MoreHide Full Article
Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Baxter International (BAX - Free Report) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? Let's take a closer look at the stock's year-to-date performance to find out.
Baxter International is one of 917 individual stocks in the Medical sector. Collectively, these companies sit at #10 in the Zacks Sector Rank. The Zacks Sector Rank considers 16 different sector groups. The average Zacks Rank of the individual stocks within the groups is measured, and the sectors are listed from best to worst.
The Zacks Rank emphasizes earnings estimates and estimate revisions to find stocks with improving earnings outlooks. This system has a long record of success, and these stocks tend to be on track to beat the market over the next one to three months. Baxter International is currently sporting a Zacks Rank of #2 (Buy).
The Zacks Consensus Estimate for BAX's full-year earnings has moved 6.5% higher within the past quarter. This signals that analyst sentiment is improving and the stock's earnings outlook is more positive.
Our latest available data shows that BAX has returned about 26.7% since the start of the calendar year. At the same time, Medical stocks have lost an average of 0.2%. This shows that Baxter International is outperforming its peers so far this year.
Another stock in the Medical sector, Bayer Aktiengesellschaft (BAYRY - Free Report) , has outperformed the sector so far this year. The stock's year-to-date return is 14.5%.
In Bayer Aktiengesellschaft's case, the consensus EPS estimate for the current year increased 2.1% over the past three months. The stock currently has a Zacks Rank #2 (Buy).
Looking more specifically, Baxter International belongs to the Medical - Products industry, a group that includes 82 individual stocks and currently sits at #161 in the Zacks Industry Rank. On average, this group has lost an average of 22.4% so far this year, meaning that BAX is performing better in terms of year-to-date returns.
In contrast, Bayer Aktiengesellschaft falls under the Large Cap Pharmaceuticals industry. Currently, this industry has 11 stocks and is ranked #100. Since the beginning of the year, the industry has moved +8.9%.
Going forward, investors interested in Medical stocks should continue to pay close attention to Baxter International and Bayer Aktiengesellschaft as they could maintain their solid performance.
View the Zacks #1 Rank List
Image: Bigstock
Is Baxter International (BAX) Stock Outpacing Its Medical Peers This Year?
Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Baxter International (BAX - Free Report) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? Let's take a closer look at the stock's year-to-date performance to find out.
Baxter International is one of 917 individual stocks in the Medical sector. Collectively, these companies sit at #10 in the Zacks Sector Rank. The Zacks Sector Rank considers 16 different sector groups. The average Zacks Rank of the individual stocks within the groups is measured, and the sectors are listed from best to worst.
The Zacks Rank emphasizes earnings estimates and estimate revisions to find stocks with improving earnings outlooks. This system has a long record of success, and these stocks tend to be on track to beat the market over the next one to three months. Baxter International is currently sporting a Zacks Rank of #2 (Buy).
The Zacks Consensus Estimate for BAX's full-year earnings has moved 6.5% higher within the past quarter. This signals that analyst sentiment is improving and the stock's earnings outlook is more positive.
Our latest available data shows that BAX has returned about 26.7% since the start of the calendar year. At the same time, Medical stocks have lost an average of 0.2%. This shows that Baxter International is outperforming its peers so far this year.
Another stock in the Medical sector, Bayer Aktiengesellschaft (BAYRY - Free Report) , has outperformed the sector so far this year. The stock's year-to-date return is 14.5%.
In Bayer Aktiengesellschaft's case, the consensus EPS estimate for the current year increased 2.1% over the past three months. The stock currently has a Zacks Rank #2 (Buy).
Looking more specifically, Baxter International belongs to the Medical - Products industry, a group that includes 82 individual stocks and currently sits at #161 in the Zacks Industry Rank. On average, this group has lost an average of 22.4% so far this year, meaning that BAX is performing better in terms of year-to-date returns.
In contrast, Bayer Aktiengesellschaft falls under the Large Cap Pharmaceuticals industry. Currently, this industry has 11 stocks and is ranked #100. Since the beginning of the year, the industry has moved +8.9%.
Going forward, investors interested in Medical stocks should continue to pay close attention to Baxter International and Bayer Aktiengesellschaft as they could maintain their solid performance.